Synergistic Redox Modulation by Pomegranate Peel–Derived CeO₂–CuO Nanocomposites in Colorectal Cancer Cells
DOI:
https://doi.org/10.65795/x292sz39Keywords:
copper oxide, cerium oxide, nanotechnology, anti-cancer, green synthesisAbstract
Nanotechnology has emerged as a promising field in cancer therapy, offering innovative solutions through the design of multifunctional nanomaterials. Among them, metal oxide nanocomposites are gaining attention due to their unique physicochemical properties and biomedical potential. However, conventional synthesis methods often involve toxic chemicals and generate environmental hazards. To overcome these challenges, green synthesis using plant-based extracts provides an eco-friendly, cost-effective, and sustainable alternative. Pomegranate peel, a rich source of polyphenols and antioxidants, has shown potential in nanoparticle synthesis by acting as a natural reducing and stabilizing agent. This study aimed to develop an eco-friendly synthesis approach for (CeO₂)-(CuO) nanocomposites while investigating their physicochemical characteristics and therapeutic efficacy as an anticancer agent. The synthesis utilized pomegranate peel extract as a reducing and capping agent, combined with Cupric acetate monohydrate and Cerium nitrate. Characterization techniques such as Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and Transmission Electron Microscopy (TEM) were employed to analyze the nanocomposites' structural and morphological properties. The anticancer activity was evaluated using an MTT assay on HCT116 colorectal cancer cells, determining cell viability and IC₅₀ values. The FTIR analysis confirmed the successful integration of organic components from pomegranate peel with metal oxides in the nanocomposite. XRD analysis revealed well-defined crystalline structures, while TEM imaging showed spherical nanoparticles with an average size of 48 nm. The MTT assay demonstrated dose-dependent cytotoxicity, with the nanocomposite inducing significant apoptotic changes in HCT116 cells at higher concentrations. The green synthesis approach successfully produced a (CeO₂)-(CuO) nanocomposite with potent anticancer activity, underscoring its potential as a sustainable therapeutic agent. The study highlights the benefits of utilizing agro-industrial waste and developing effective nanomaterials for biomedical applications. Future research should focus on in vivo validation and detailed mechanistic studies.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Sherene Kristin, Rajakumar Govindasamy, Suganya Panneer Selvam, Dhivya Viswanathan (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright and Licensing
All articles published in Trends in Biomaterials and Artificial Organs are published Open Access. To ensure the widest possible dissemination of research while protecting the integrity of the original work, we utilize the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) 4.0 International License.
User Rights
Under this license, the public is free to share (copy and redistribute the material in any medium or format) under the following terms:
- Attribution: Users must give appropriate credit, provide a link to the license, and indicate if changes were made.
- Non-Commercial: Users may not use the material for commercial purposes. This includes, but is not limited to, the sale of the article or its use in promotional materials for-profit.
- No Derivatives: If a user remixes, transforms, or builds upon the material, they may not distribute the modified material.
Author Rights
Authors retain copyright of their work while granting the journal a non-exclusive license to publish. Because of the NoDerivs (ND) and Non-Commercial (NC) designations:
- Third parties (such as other researchers) must seek permission from the authors/journal to include figures, tables, or portions of the text in new works or commercial publications.
- Authors may deposit the "Version of Record" in institutional repositories immediately upon publication, provided the CC BY-NC-ND 4.0 license is clearly linked.
How to Cite
Accepted 05-05-2026
Published 09-07-2026


